{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-172166","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.513182+00:00","generated_at":"2026-06-01T00:39:37.931693+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"ARS Pharmaceuticals updates corporate presentation; no new material financial data disclosed in filing text","bullets":["ARS Pharmaceuticals (SPRY) filed an updated corporate presentation on June 28, 2024, under Item 7.01 FD disclosure.","The filing text does not contain specific new financial, operational, or strategic details; only a presentation title is provided.","No revenue, EPS, guidance, or other material metrics are available from the excerpted exhibit.","The 8-K is a routine update for investor meetings; no event-type triggers (earnings, M&A, leadership change) are indicated."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-172166","json":"https://secwatch.observer/filing/0001193125-24-172166.json","markdown":"https://secwatch.observer/filing/0001193125-24-172166.md","text":"https://secwatch.observer/filing/0001193125-24-172166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312524172166/0001193125-24-172166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312524172166/d835427d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:39:37.931693+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}